Coya Therapeutics Inc
COYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$112.83M
Close$
$-0.41
108.8% downside
Current Fair Value
108.8% downsideOvervalued by 108.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $112.83 Million |
|---|---|
| Enterprise Value | $-41,834,720,945.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 0.6 |
| Outstanding Shares | 16,730,274 |
Return
| Return on Equity | -4.93% |
|---|---|
| Return on Assets | -4.51% |
| Return on Invested Capital | -4.87% |
Valuation & Multiples
| P/E Ratio | -4.18 |
|---|---|
| PEG | 4.19 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -11.72 |
| Enterprise Value to EBIT | 19.6 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$130,000
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
$150,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 63,400▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.61%▲ 1.16% |
|---|---|
| Total Invested | $32.05M▼ 30.40% |
| Investors Holding | 580% |
ESG Score
No data